Hims & Hers ( HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk ( NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...

She suggested I start taking the GLP-1 Zepbound through weekly injections, along with incorporating a healthy diet and ...

TD Cowen downgraded Hims & Hers Health to "Hold" from "Buy" citing a lack of near-term catalysts and concerns over the company’s weight loss revenue guidance in a post-compounded GLP-1 ...

SHOPPING: Take steps to achieve your body goals with Hers, the weight loss program that takes into account your specific ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering ...

While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...

Millions of Americans are turning to popular GLP-1 drugs to help them lose weight — and while many have found weight loss success while taking these medicines, the number on ...

Apyx Medical Corporation (Nasdaq: APYX) ("Apyx Medical” or the "Company”), the manufacturer of a proprietary helium plasma ...

Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...